nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—CYP3A7—Ifosfamide—testicular cancer	0.145	0.22	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.145	0.22	CbGbCtD
Alprazolam—CYP3A5—Ifosfamide—testicular cancer	0.109	0.165	CbGbCtD
Alprazolam—CYP2C9—Ifosfamide—testicular cancer	0.073	0.111	CbGbCtD
Alprazolam—CYP3A5—Etoposide—testicular cancer	0.052	0.079	CbGbCtD
Alprazolam—CYP3A4—Ifosfamide—testicular cancer	0.0425	0.0644	CbGbCtD
Alprazolam—CYP2C9—Cisplatin—testicular cancer	0.0355	0.0539	CbGbCtD
Alprazolam—CYP3A4—Vinblastine—testicular cancer	0.0225	0.0342	CbGbCtD
Alprazolam—CYP3A4—Etoposide—testicular cancer	0.0203	0.0308	CbGbCtD
Alprazolam—CYP3A4—Doxorubicin—testicular cancer	0.0138	0.021	CbGbCtD
Alprazolam—Drowsiness—Epirubicin—testicular cancer	0.000345	0.00101	CcSEcCtD
Alprazolam—Vomiting—Dactinomycin—testicular cancer	0.000345	0.00101	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000342	0.001	CcSEcCtD
Alprazolam—Rash—Dactinomycin—testicular cancer	0.000342	0.001	CcSEcCtD
Alprazolam—Decreased appetite—Etoposide—testicular cancer	0.000342	0.001	CcSEcCtD
Alprazolam—Diarrhoea—Ifosfamide—testicular cancer	0.00034	0.000998	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Etoposide—testicular cancer	0.000339	0.000995	CcSEcCtD
Alprazolam—Body temperature increased—Cisplatin—testicular cancer	0.000339	0.000994	CcSEcCtD
Alprazolam—Fatigue—Etoposide—testicular cancer	0.000339	0.000993	CcSEcCtD
Alprazolam—Jaundice—Epirubicin—testicular cancer	0.000337	0.000987	CcSEcCtD
Alprazolam—Constipation—Etoposide—testicular cancer	0.000336	0.000985	CcSEcCtD
Alprazolam—Dysuria—Doxorubicin—testicular cancer	0.000335	0.000983	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000333	0.000977	CcSEcCtD
Alprazolam—Hepatitis—Methotrexate—testicular cancer	0.000331	0.000971	CcSEcCtD
Alprazolam—Sweating—Epirubicin—testicular cancer	0.000331	0.000971	CcSEcCtD
Alprazolam—Pollakiuria—Doxorubicin—testicular cancer	0.000331	0.000971	CcSEcCtD
Alprazolam—Dizziness—Ifosfamide—testicular cancer	0.000329	0.000965	CcSEcCtD
Alprazolam—Urinary tract disorder—Methotrexate—testicular cancer	0.000327	0.000959	CcSEcCtD
Alprazolam—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000327	0.000959	CcSEcCtD
Alprazolam—Hepatobiliary disease—Epirubicin—testicular cancer	0.000327	0.000958	CcSEcCtD
Alprazolam—Weight increased—Doxorubicin—testicular cancer	0.000326	0.000956	CcSEcCtD
Alprazolam—Epistaxis—Epirubicin—testicular cancer	0.000326	0.000955	CcSEcCtD
Alprazolam—Urethral disorder—Methotrexate—testicular cancer	0.000325	0.000952	CcSEcCtD
Alprazolam—Weight decreased—Doxorubicin—testicular cancer	0.000324	0.000951	CcSEcCtD
Alprazolam—Feeling abnormal—Etoposide—testicular cancer	0.000324	0.000949	CcSEcCtD
Alprazolam—Nausea—Dactinomycin—testicular cancer	0.000322	0.000946	CcSEcCtD
Alprazolam—Gastrointestinal pain—Etoposide—testicular cancer	0.000321	0.000942	CcSEcCtD
Alprazolam—Infestation—Doxorubicin—testicular cancer	0.00032	0.000937	CcSEcCtD
Alprazolam—Infestation NOS—Doxorubicin—testicular cancer	0.00032	0.000937	CcSEcCtD
Alprazolam—Drowsiness—Doxorubicin—testicular cancer	0.00032	0.000937	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000317	0.000929	CcSEcCtD
Alprazolam—Vomiting—Ifosfamide—testicular cancer	0.000316	0.000928	CcSEcCtD
Alprazolam—Hypersensitivity—Cisplatin—testicular cancer	0.000316	0.000927	CcSEcCtD
Alprazolam—Rash—Ifosfamide—testicular cancer	0.000314	0.00092	CcSEcCtD
Alprazolam—Dermatitis—Ifosfamide—testicular cancer	0.000313	0.000919	CcSEcCtD
Alprazolam—Erythema multiforme—Methotrexate—testicular cancer	0.000313	0.000918	CcSEcCtD
Alprazolam—Urticaria—Etoposide—testicular cancer	0.000312	0.000915	CcSEcCtD
Alprazolam—Jaundice—Doxorubicin—testicular cancer	0.000311	0.000913	CcSEcCtD
Alprazolam—Abdominal pain—Etoposide—testicular cancer	0.000311	0.000911	CcSEcCtD
Alprazolam—Body temperature increased—Etoposide—testicular cancer	0.000311	0.000911	CcSEcCtD
Alprazolam—Hepatitis—Epirubicin—testicular cancer	0.00031	0.000909	CcSEcCtD
Alprazolam—Eye disorder—Methotrexate—testicular cancer	0.00031	0.000908	CcSEcCtD
Alprazolam—Tinnitus—Methotrexate—testicular cancer	0.000309	0.000906	CcSEcCtD
Alprazolam—Hypoaesthesia—Epirubicin—testicular cancer	0.000308	0.000905	CcSEcCtD
Alprazolam—Asthenia—Cisplatin—testicular cancer	0.000308	0.000902	CcSEcCtD
Alprazolam—Cardiac disorder—Methotrexate—testicular cancer	0.000307	0.000902	CcSEcCtD
Alprazolam—Sweating—Doxorubicin—testicular cancer	0.000306	0.000898	CcSEcCtD
Alprazolam—Urinary tract disorder—Epirubicin—testicular cancer	0.000306	0.000898	CcSEcCtD
Alprazolam—Oedema peripheral—Epirubicin—testicular cancer	0.000305	0.000896	CcSEcCtD
Alprazolam—Connective tissue disorder—Epirubicin—testicular cancer	0.000305	0.000893	CcSEcCtD
Alprazolam—Urethral disorder—Epirubicin—testicular cancer	0.000304	0.000891	CcSEcCtD
Alprazolam—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000302	0.000886	CcSEcCtD
Alprazolam—Epistaxis—Doxorubicin—testicular cancer	0.000301	0.000884	CcSEcCtD
Alprazolam—Angiopathy—Methotrexate—testicular cancer	0.000301	0.000881	CcSEcCtD
Alprazolam—Mediastinal disorder—Methotrexate—testicular cancer	0.000299	0.000875	CcSEcCtD
Alprazolam—Chills—Methotrexate—testicular cancer	0.000297	0.000872	CcSEcCtD
Alprazolam—Nausea—Ifosfamide—testicular cancer	0.000296	0.000867	CcSEcCtD
Alprazolam—Diarrhoea—Cisplatin—testicular cancer	0.000293	0.000861	CcSEcCtD
Alprazolam—Erythema multiforme—Epirubicin—testicular cancer	0.000293	0.00086	CcSEcCtD
Alprazolam—Mental disorder—Methotrexate—testicular cancer	0.00029	0.000851	CcSEcCtD
Alprazolam—Eye disorder—Epirubicin—testicular cancer	0.00029	0.00085	CcSEcCtD
Alprazolam—Hypersensitivity—Etoposide—testicular cancer	0.00029	0.000849	CcSEcCtD
Alprazolam—Tinnitus—Epirubicin—testicular cancer	0.000289	0.000848	CcSEcCtD
Alprazolam—Malnutrition—Methotrexate—testicular cancer	0.000288	0.000846	CcSEcCtD
Alprazolam—Cardiac disorder—Epirubicin—testicular cancer	0.000288	0.000844	CcSEcCtD
Alprazolam—Hepatitis—Doxorubicin—testicular cancer	0.000287	0.000841	CcSEcCtD
Alprazolam—Hypoaesthesia—Doxorubicin—testicular cancer	0.000285	0.000837	CcSEcCtD
Alprazolam—Urinary tract disorder—Doxorubicin—testicular cancer	0.000283	0.000831	CcSEcCtD
Alprazolam—Oedema peripheral—Doxorubicin—testicular cancer	0.000283	0.000829	CcSEcCtD
Alprazolam—Asthenia—Etoposide—testicular cancer	0.000282	0.000827	CcSEcCtD
Alprazolam—Connective tissue disorder—Doxorubicin—testicular cancer	0.000282	0.000827	CcSEcCtD
Alprazolam—Angiopathy—Epirubicin—testicular cancer	0.000281	0.000825	CcSEcCtD
Alprazolam—Urethral disorder—Doxorubicin—testicular cancer	0.000281	0.000825	CcSEcCtD
Alprazolam—Mediastinal disorder—Epirubicin—testicular cancer	0.000279	0.000819	CcSEcCtD
Alprazolam—Back pain—Methotrexate—testicular cancer	0.000279	0.000818	CcSEcCtD
Alprazolam—Chills—Epirubicin—testicular cancer	0.000278	0.000816	CcSEcCtD
Alprazolam—Pruritus—Etoposide—testicular cancer	0.000278	0.000815	CcSEcCtD
Alprazolam—Vomiting—Cisplatin—testicular cancer	0.000273	0.0008	CcSEcCtD
Alprazolam—Vision blurred—Methotrexate—testicular cancer	0.000272	0.000797	CcSEcCtD
Alprazolam—Mental disorder—Epirubicin—testicular cancer	0.000272	0.000796	CcSEcCtD
Alprazolam—Erythema multiforme—Doxorubicin—testicular cancer	0.000271	0.000795	CcSEcCtD
Alprazolam—Rash—Cisplatin—testicular cancer	0.00027	0.000793	CcSEcCtD
Alprazolam—Dermatitis—Cisplatin—testicular cancer	0.00027	0.000792	CcSEcCtD
Alprazolam—Malnutrition—Epirubicin—testicular cancer	0.00027	0.000791	CcSEcCtD
Alprazolam—Diarrhoea—Etoposide—testicular cancer	0.000269	0.000788	CcSEcCtD
Alprazolam—Eye disorder—Doxorubicin—testicular cancer	0.000268	0.000786	CcSEcCtD
Alprazolam—Ill-defined disorder—Methotrexate—testicular cancer	0.000268	0.000785	CcSEcCtD
Alprazolam—Tinnitus—Doxorubicin—testicular cancer	0.000267	0.000784	CcSEcCtD
Alprazolam—Cardiac disorder—Doxorubicin—testicular cancer	0.000266	0.000781	CcSEcCtD
Alprazolam—Tension—Epirubicin—testicular cancer	0.000265	0.000777	CcSEcCtD
Alprazolam—Nervousness—Epirubicin—testicular cancer	0.000262	0.000769	CcSEcCtD
Alprazolam—Back pain—Epirubicin—testicular cancer	0.000261	0.000765	CcSEcCtD
Alprazolam—Angiopathy—Doxorubicin—testicular cancer	0.00026	0.000763	CcSEcCtD
Alprazolam—Malaise—Methotrexate—testicular cancer	0.00026	0.000763	CcSEcCtD
Alprazolam—Dizziness—Etoposide—testicular cancer	0.00026	0.000762	CcSEcCtD
Alprazolam—Muscle spasms—Epirubicin—testicular cancer	0.000259	0.000761	CcSEcCtD
Alprazolam—Vertigo—Methotrexate—testicular cancer	0.000259	0.00076	CcSEcCtD
Alprazolam—Mediastinal disorder—Doxorubicin—testicular cancer	0.000259	0.000758	CcSEcCtD
Alprazolam—Chills—Doxorubicin—testicular cancer	0.000257	0.000755	CcSEcCtD
Alprazolam—Nausea—Cisplatin—testicular cancer	0.000255	0.000747	CcSEcCtD
Alprazolam—Vision blurred—Epirubicin—testicular cancer	0.000254	0.000746	CcSEcCtD
Alprazolam—Mental disorder—Doxorubicin—testicular cancer	0.000251	0.000737	CcSEcCtD
Alprazolam—Ill-defined disorder—Epirubicin—testicular cancer	0.00025	0.000734	CcSEcCtD
Alprazolam—Convulsion—Methotrexate—testicular cancer	0.00025	0.000733	CcSEcCtD
Alprazolam—Vomiting—Etoposide—testicular cancer	0.00025	0.000733	CcSEcCtD
Alprazolam—Malnutrition—Doxorubicin—testicular cancer	0.00025	0.000732	CcSEcCtD
Alprazolam—Agitation—Epirubicin—testicular cancer	0.000248	0.000727	CcSEcCtD
Alprazolam—Rash—Etoposide—testicular cancer	0.000248	0.000726	CcSEcCtD
Alprazolam—Dermatitis—Etoposide—testicular cancer	0.000248	0.000726	CcSEcCtD
Alprazolam—Headache—Etoposide—testicular cancer	0.000246	0.000722	CcSEcCtD
Alprazolam—Arthralgia—Methotrexate—testicular cancer	0.000246	0.00072	CcSEcCtD
Alprazolam—Chest pain—Methotrexate—testicular cancer	0.000246	0.00072	CcSEcCtD
Alprazolam—Myalgia—Methotrexate—testicular cancer	0.000246	0.00072	CcSEcCtD
Alprazolam—Tension—Doxorubicin—testicular cancer	0.000245	0.000719	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000244	0.000715	CcSEcCtD
Alprazolam—Malaise—Epirubicin—testicular cancer	0.000243	0.000714	CcSEcCtD
Alprazolam—Discomfort—Methotrexate—testicular cancer	0.000243	0.000711	CcSEcCtD
Alprazolam—Nervousness—Doxorubicin—testicular cancer	0.000243	0.000711	CcSEcCtD
Alprazolam—Vertigo—Epirubicin—testicular cancer	0.000242	0.000711	CcSEcCtD
Alprazolam—Syncope—Epirubicin—testicular cancer	0.000242	0.00071	CcSEcCtD
Alprazolam—Back pain—Doxorubicin—testicular cancer	0.000242	0.000708	CcSEcCtD
Alprazolam—Muscle spasms—Doxorubicin—testicular cancer	0.00024	0.000704	CcSEcCtD
Alprazolam—Palpitations—Epirubicin—testicular cancer	0.000239	0.000699	CcSEcCtD
Alprazolam—Confusional state—Methotrexate—testicular cancer	0.000237	0.000696	CcSEcCtD
Alprazolam—Loss of consciousness—Epirubicin—testicular cancer	0.000237	0.000696	CcSEcCtD
Alprazolam—Vision blurred—Doxorubicin—testicular cancer	0.000235	0.00069	CcSEcCtD
Alprazolam—Convulsion—Epirubicin—testicular cancer	0.000234	0.000686	CcSEcCtD
Alprazolam—Infection—Methotrexate—testicular cancer	0.000234	0.000686	CcSEcCtD
Alprazolam—Nausea—Etoposide—testicular cancer	0.000233	0.000684	CcSEcCtD
Alprazolam—Ill-defined disorder—Doxorubicin—testicular cancer	0.000232	0.000679	CcSEcCtD
Alprazolam—Nervous system disorder—Methotrexate—testicular cancer	0.000231	0.000677	CcSEcCtD
Alprazolam—Myalgia—Epirubicin—testicular cancer	0.00023	0.000674	CcSEcCtD
Alprazolam—Chest pain—Epirubicin—testicular cancer	0.00023	0.000674	CcSEcCtD
Alprazolam—Arthralgia—Epirubicin—testicular cancer	0.00023	0.000674	CcSEcCtD
Alprazolam—Agitation—Doxorubicin—testicular cancer	0.000229	0.000673	CcSEcCtD
Alprazolam—Anxiety—Epirubicin—testicular cancer	0.000229	0.000671	CcSEcCtD
Alprazolam—Skin disorder—Methotrexate—testicular cancer	0.000229	0.00067	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000228	0.000669	CcSEcCtD
Alprazolam—Hyperhidrosis—Methotrexate—testicular cancer	0.000228	0.000667	CcSEcCtD
Alprazolam—Discomfort—Epirubicin—testicular cancer	0.000227	0.000666	CcSEcCtD
Alprazolam—Malaise—Doxorubicin—testicular cancer	0.000225	0.00066	CcSEcCtD
Alprazolam—Dry mouth—Epirubicin—testicular cancer	0.000225	0.000659	CcSEcCtD
Alprazolam—Vertigo—Doxorubicin—testicular cancer	0.000224	0.000658	CcSEcCtD
Alprazolam—Anorexia—Methotrexate—testicular cancer	0.000224	0.000658	CcSEcCtD
Alprazolam—Syncope—Doxorubicin—testicular cancer	0.000224	0.000657	CcSEcCtD
Alprazolam—Confusional state—Epirubicin—testicular cancer	0.000222	0.000651	CcSEcCtD
Alprazolam—Palpitations—Doxorubicin—testicular cancer	0.000221	0.000647	CcSEcCtD
Alprazolam—Oedema—Epirubicin—testicular cancer	0.00022	0.000646	CcSEcCtD
Alprazolam—Hypotension—Methotrexate—testicular cancer	0.00022	0.000645	CcSEcCtD
Alprazolam—Loss of consciousness—Doxorubicin—testicular cancer	0.000219	0.000644	CcSEcCtD
Alprazolam—Infection—Epirubicin—testicular cancer	0.000219	0.000642	CcSEcCtD
Alprazolam—Shock—Epirubicin—testicular cancer	0.000217	0.000635	CcSEcCtD
Alprazolam—Convulsion—Doxorubicin—testicular cancer	0.000216	0.000634	CcSEcCtD
Alprazolam—Nervous system disorder—Epirubicin—testicular cancer	0.000216	0.000633	CcSEcCtD
Alprazolam—Tachycardia—Epirubicin—testicular cancer	0.000215	0.00063	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000214	0.000629	CcSEcCtD
Alprazolam—Skin disorder—Epirubicin—testicular cancer	0.000214	0.000627	CcSEcCtD
Alprazolam—Hyperhidrosis—Epirubicin—testicular cancer	0.000213	0.000624	CcSEcCtD
Alprazolam—Insomnia—Methotrexate—testicular cancer	0.000213	0.000624	CcSEcCtD
Alprazolam—Chest pain—Doxorubicin—testicular cancer	0.000213	0.000623	CcSEcCtD
Alprazolam—Arthralgia—Doxorubicin—testicular cancer	0.000213	0.000623	CcSEcCtD
Alprazolam—Myalgia—Doxorubicin—testicular cancer	0.000213	0.000623	CcSEcCtD
Alprazolam—Anxiety—Doxorubicin—testicular cancer	0.000212	0.000621	CcSEcCtD
Alprazolam—Paraesthesia—Methotrexate—testicular cancer	0.000211	0.00062	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000211	0.000619	CcSEcCtD
Alprazolam—Discomfort—Doxorubicin—testicular cancer	0.00021	0.000616	CcSEcCtD
Alprazolam—Anorexia—Epirubicin—testicular cancer	0.00021	0.000616	CcSEcCtD
Alprazolam—Dyspnoea—Methotrexate—testicular cancer	0.00021	0.000615	CcSEcCtD
Alprazolam—Somnolence—Methotrexate—testicular cancer	0.000209	0.000614	CcSEcCtD
Alprazolam—Dry mouth—Doxorubicin—testicular cancer	0.000208	0.00061	CcSEcCtD
Alprazolam—Dyspepsia—Methotrexate—testicular cancer	0.000207	0.000607	CcSEcCtD
Alprazolam—Hypotension—Epirubicin—testicular cancer	0.000206	0.000604	CcSEcCtD
Alprazolam—Confusional state—Doxorubicin—testicular cancer	0.000206	0.000603	CcSEcCtD
Alprazolam—Decreased appetite—Methotrexate—testicular cancer	0.000205	0.0006	CcSEcCtD
Alprazolam—Oedema—Doxorubicin—testicular cancer	0.000204	0.000598	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000203	0.000596	CcSEcCtD
Alprazolam—Fatigue—Methotrexate—testicular cancer	0.000203	0.000595	CcSEcCtD
Alprazolam—Infection—Doxorubicin—testicular cancer	0.000202	0.000594	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000201	0.000588	CcSEcCtD
Alprazolam—Shock—Doxorubicin—testicular cancer	0.000201	0.000588	CcSEcCtD
Alprazolam—Nervous system disorder—Doxorubicin—testicular cancer	0.0002	0.000586	CcSEcCtD
Alprazolam—Insomnia—Epirubicin—testicular cancer	0.000199	0.000584	CcSEcCtD
Alprazolam—Tachycardia—Doxorubicin—testicular cancer	0.000199	0.000583	CcSEcCtD
Alprazolam—Skin disorder—Doxorubicin—testicular cancer	0.000198	0.00058	CcSEcCtD
Alprazolam—Paraesthesia—Epirubicin—testicular cancer	0.000198	0.00058	CcSEcCtD
Alprazolam—Hyperhidrosis—Doxorubicin—testicular cancer	0.000197	0.000578	CcSEcCtD
Alprazolam—Dyspnoea—Epirubicin—testicular cancer	0.000196	0.000576	CcSEcCtD
Alprazolam—Somnolence—Epirubicin—testicular cancer	0.000196	0.000574	CcSEcCtD
Alprazolam—Anorexia—Doxorubicin—testicular cancer	0.000194	0.00057	CcSEcCtD
Alprazolam—Feeling abnormal—Methotrexate—testicular cancer	0.000194	0.000569	CcSEcCtD
Alprazolam—Dyspepsia—Epirubicin—testicular cancer	0.000194	0.000569	CcSEcCtD
Alprazolam—Gastrointestinal pain—Methotrexate—testicular cancer	0.000192	0.000564	CcSEcCtD
Alprazolam—Decreased appetite—Epirubicin—testicular cancer	0.000191	0.000561	CcSEcCtD
Alprazolam—Hypotension—Doxorubicin—testicular cancer	0.00019	0.000558	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00019	0.000558	CcSEcCtD
Alprazolam—Fatigue—Epirubicin—testicular cancer	0.00019	0.000557	CcSEcCtD
Alprazolam—Constipation—Epirubicin—testicular cancer	0.000188	0.000552	CcSEcCtD
Alprazolam—Urticaria—Methotrexate—testicular cancer	0.000187	0.000548	CcSEcCtD
Alprazolam—Body temperature increased—Methotrexate—testicular cancer	0.000186	0.000546	CcSEcCtD
Alprazolam—Abdominal pain—Methotrexate—testicular cancer	0.000186	0.000546	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000186	0.000544	CcSEcCtD
Alprazolam—Insomnia—Doxorubicin—testicular cancer	0.000184	0.00054	CcSEcCtD
Alprazolam—Paraesthesia—Doxorubicin—testicular cancer	0.000183	0.000537	CcSEcCtD
Alprazolam—Dyspnoea—Doxorubicin—testicular cancer	0.000182	0.000533	CcSEcCtD
Alprazolam—Feeling abnormal—Epirubicin—testicular cancer	0.000182	0.000532	CcSEcCtD
Alprazolam—Somnolence—Doxorubicin—testicular cancer	0.000181	0.000531	CcSEcCtD
Alprazolam—Gastrointestinal pain—Epirubicin—testicular cancer	0.00018	0.000528	CcSEcCtD
Alprazolam—Dyspepsia—Doxorubicin—testicular cancer	0.000179	0.000526	CcSEcCtD
Alprazolam—Decreased appetite—Doxorubicin—testicular cancer	0.000177	0.000519	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000176	0.000516	CcSEcCtD
Alprazolam—Fatigue—Doxorubicin—testicular cancer	0.000176	0.000515	CcSEcCtD
Alprazolam—Urticaria—Epirubicin—testicular cancer	0.000175	0.000513	CcSEcCtD
Alprazolam—Constipation—Doxorubicin—testicular cancer	0.000174	0.000511	CcSEcCtD
Alprazolam—Abdominal pain—Epirubicin—testicular cancer	0.000174	0.000511	CcSEcCtD
Alprazolam—Body temperature increased—Epirubicin—testicular cancer	0.000174	0.000511	CcSEcCtD
Alprazolam—Hypersensitivity—Methotrexate—testicular cancer	0.000173	0.000508	CcSEcCtD
Alprazolam—Asthenia—Methotrexate—testicular cancer	0.000169	0.000495	CcSEcCtD
Alprazolam—Feeling abnormal—Doxorubicin—testicular cancer	0.000168	0.000492	CcSEcCtD
Alprazolam—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000167	0.000489	CcSEcCtD
Alprazolam—Pruritus—Methotrexate—testicular cancer	0.000167	0.000488	CcSEcCtD
Alprazolam—Hypersensitivity—Epirubicin—testicular cancer	0.000162	0.000476	CcSEcCtD
Alprazolam—Urticaria—Doxorubicin—testicular cancer	0.000162	0.000475	CcSEcCtD
Alprazolam—Abdominal pain—Doxorubicin—testicular cancer	0.000161	0.000472	CcSEcCtD
Alprazolam—Body temperature increased—Doxorubicin—testicular cancer	0.000161	0.000472	CcSEcCtD
Alprazolam—Diarrhoea—Methotrexate—testicular cancer	0.000161	0.000472	CcSEcCtD
Alprazolam—Asthenia—Epirubicin—testicular cancer	0.000158	0.000463	CcSEcCtD
Alprazolam—Pruritus—Epirubicin—testicular cancer	0.000156	0.000457	CcSEcCtD
Alprazolam—Dizziness—Methotrexate—testicular cancer	0.000156	0.000456	CcSEcCtD
Alprazolam—Diarrhoea—Epirubicin—testicular cancer	0.000151	0.000442	CcSEcCtD
Alprazolam—Hypersensitivity—Doxorubicin—testicular cancer	0.00015	0.00044	CcSEcCtD
Alprazolam—Vomiting—Methotrexate—testicular cancer	0.00015	0.000439	CcSEcCtD
Alprazolam—Rash—Methotrexate—testicular cancer	0.000148	0.000435	CcSEcCtD
Alprazolam—Dermatitis—Methotrexate—testicular cancer	0.000148	0.000435	CcSEcCtD
Alprazolam—Headache—Methotrexate—testicular cancer	0.000147	0.000432	CcSEcCtD
Alprazolam—Asthenia—Doxorubicin—testicular cancer	0.000146	0.000429	CcSEcCtD
Alprazolam—Dizziness—Epirubicin—testicular cancer	0.000146	0.000427	CcSEcCtD
Alprazolam—Pruritus—Doxorubicin—testicular cancer	0.000144	0.000423	CcSEcCtD
Alprazolam—Vomiting—Epirubicin—testicular cancer	0.00014	0.000411	CcSEcCtD
Alprazolam—Nausea—Methotrexate—testicular cancer	0.00014	0.00041	CcSEcCtD
Alprazolam—Diarrhoea—Doxorubicin—testicular cancer	0.000139	0.000409	CcSEcCtD
Alprazolam—Rash—Epirubicin—testicular cancer	0.000139	0.000407	CcSEcCtD
Alprazolam—Dermatitis—Epirubicin—testicular cancer	0.000139	0.000407	CcSEcCtD
Alprazolam—Headache—Epirubicin—testicular cancer	0.000138	0.000405	CcSEcCtD
Alprazolam—Dizziness—Doxorubicin—testicular cancer	0.000135	0.000395	CcSEcCtD
Alprazolam—Nausea—Epirubicin—testicular cancer	0.000131	0.000384	CcSEcCtD
Alprazolam—Vomiting—Doxorubicin—testicular cancer	0.00013	0.00038	CcSEcCtD
Alprazolam—Rash—Doxorubicin—testicular cancer	0.000129	0.000377	CcSEcCtD
Alprazolam—Dermatitis—Doxorubicin—testicular cancer	0.000128	0.000376	CcSEcCtD
Alprazolam—Headache—Doxorubicin—testicular cancer	0.000128	0.000374	CcSEcCtD
Alprazolam—Nausea—Doxorubicin—testicular cancer	0.000121	0.000355	CcSEcCtD
